Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Field

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
The Journal of General Virology|November 1, 1993
Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection modelM Azmi, H J Field
Pharmacology & Therapeutics|January 1, 1983
Latency and acquired resistance--problems in chemotherapy of herpes infectionsG Darby, H J Field
Antiviral Research|October 1, 1982
Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovirH J Field, J Neden
British Medical Journal (Clinical Research Ed.)|June 6, 1981
Recurrent herpes simplex: the outlook for systemic antiviral agentsH J Field, P Wildy
The Journal of Hygiene|October 1, 1978
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in miceH J Field, P Wildy
Sexually Transmitted Infections|June 20, 1998
Can HSV latency be conquered by current antiviral therapies?A Simmons, H J Field
Current Topics in Microbiology and Immunology|June 22, 2001
Neuronal latency in human and animal herpesvirus infectionsK Borchers, H J Field
Antiviral Research|April 1, 1984
Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovirH J Field, E Lay
Lancet (London, England)|May 15, 1982
Clinical resistance of herpes simplex virus to acyclovirH J Field, P Wildy
The Journal of General Virology|February 1, 1993
Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cellsM Azmi, H J Field
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
The Journal of General Virology|November 1, 1993
Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection modelM Azmi, H J Field
Pharmacology & Therapeutics|January 1, 1983
Latency and acquired resistance--problems in chemotherapy of herpes infectionsG Darby, H J Field
Antiviral Research|October 1, 1982
Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovirH J Field, J Neden
British Medical Journal (Clinical Research Ed.)|June 6, 1981
Recurrent herpes simplex: the outlook for systemic antiviral agentsH J Field, P Wildy
The Journal of Hygiene|October 1, 1978
The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in miceH J Field, P Wildy
Sexually Transmitted Infections|June 20, 1998
Can HSV latency be conquered by current antiviral therapies?A Simmons, H J Field
Current Topics in Microbiology and Immunology|June 22, 2001
Neuronal latency in human and animal herpesvirus infectionsK Borchers, H J Field
Antiviral Research|April 1, 1984
Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovirH J Field, E Lay
Lancet (London, England)|May 15, 1982
Clinical resistance of herpes simplex virus to acyclovirH J Field, P Wildy
The Journal of General Virology|February 1, 1993
Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cellsM Azmi, H J Field
Pageof 11